In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia-Reference-Cited by-同舟云学术

In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia

Published:2008-09 Issue:9 Volume:14 Page:882-886
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Bradford P.A.,Petersen P.J.,Tuckman M.,Jones C.H.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference19 articles.

1. Synthesis and structure–activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936;Sum;Bioorg Med Chem Lett,1999

2. Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent Oxyrase on in vitro activities of tigecycline against recent clinical isolates;Petersen;Antimicrob Agents Chemother,2005

3. Susceptibilities of Mycoplasma hominis, M. pneumoniae , and Ureaplasma urealyticum to GAR-936, Dalfopristin, Dirithromycin, Evernimicin, Gatifloxacin, Linezolid, Moxifloxacin, Quinupristin-Dalfopristin, and Telithromycin Compared to Their Susceptibilities to Reference Macrolides, Tetracyclines, and Quinolones

4. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis;Roblin;Int J Antimicrob Agents,2000

5. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria;Wallace;Antimicrob Agents Chemother,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial protease‐responsive shape memory polymers for infection surveillance and biofilm inhibition in chronic wounds;Journal of Biomedical Materials Research Part A;2023-03-04

2. Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates;Antimicrobial Agents and Chemotherapy;2018-05

3. Current treatment of community-acquired pneumonia;Expert Opinion on Pharmacotherapy;2013-05-10

4. Validation of an Immunodiagnostic Assay for Detection of 13 Streptococcus pneumoniae Serotype-Specific Polysaccharides in Human Urine;Clinical and Vaccine Immunology;2012-08

5. Susceptibility to Tigecycline and Linezolid Among Gram-Positive Isolates Collected in the United States as Part of the Tigecycline Evaluation and Surveillance Trial (TEST) Between 2004 and 2009;Clinical Therapeutics;2011-12